Similarly, TMEM16A expression was significantly upregulated in livers from NAFLD patients compared to those from normal controls (Figure 1H,I; and Figure S1F,G, Supporting Information). Here, ANO1 is linked to metabolic dysfunction-associated steatotic liver disease.